LandaI, CabanillasME. Genomic alterations in thyroid cancer: Biological and clinical insights. Nat Rev Endocrinol, 2024; 20(2):93–110; doi: 10.1038/s41574-023-00920-6
2.
ByunH, LeeHS, SongYS, et al.Transcriptome of anaplastic thyroid cancer reveals two molecular subtypes with distinct tumor microenvironment and prognosis. Thyroid, 2025; 35(4):367–378; doi: 10.1089/thy.2024.0266
3.
KimYH, YoonSJ, KimM, et al.Integrative multi-omics analysis reveals different metabolic phenotypes based on molecular characteristics in thyroid cancer. Clin Cancer Res, 2024; 30(4):883–894; doi: 10.1158/1078-0432.CCR-23-2025
4.
ZengPYF, ProkopecSD, LaiSY, et al.The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep, 2024; 43(3):113826; doi: 10.1016/j.celrep.2024.113826
5.
LeeSE, ParkS, YiS, et al.Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses. Nat Commun, 2024; 15(1):1163; doi: 10.1038/s41467-024-45366-0
6.
AgrawalN, AkbaniR, AksoyBA, et al.Integrated genomic characterization of papillary thyroid carcinoma. Cell, 2014; 159(3):676–690; doi: 10.1016/j.cell.2014.09.050
7.
XuGJ, LobergMA, GallantJN, et al.Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction. Cell Genom, 2023; 3(10):100409; doi: 10.1016/j.xgen.2023.100409
8.
LuL, WangJR, HendersonYC, et al.Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest, 2023; 133(11); doi: 10.1172/JCI169653
9.
LuoH, XiaX, KimGD, et al.Characterizing dedifferentiation of thyroid cancer by integrated analysis. Sci Adv, 2021; 7(31); doi: 10.1126/sciadv.abf3657
10.
BibleKC, KebebewE, BrierleyJ, et al.2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 2021; 31(3):337–386; doi: 10.1089/thy.2020.0944
